Guangdong Lifestrong Pharmacy Co. Ltd. Net Asset Quality Index
Guangdong Lifestrong Pharmacy Co. Ltd. net asset quality index. Guangdong Lifestrong Pharmacy Co. Ltd. (301111) has a Net Asset Quality Index of 83.1% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥907.89 Million minus total liabilities of CN¥153.04 Million yields net assets of CN¥754.84 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check 301111 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Guangdong Lifestrong Pharmacy Co. Ltd. (2017–2025)
Net asset quality index of Guangdong Lifestrong Pharmacy Co. Ltd. from 2017 to 2025. This chart shows how Guangdong Lifestrong Pharmacy Co. Ltd.'s Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the index stands at 83.1%, representing net assets of CN¥754.84 Million against total assets of CN¥907.89 Million CNY. See 301111 net assets for net asset value and shareholders' equity analysis.
Guangdong Lifestrong Pharmacy Co. Ltd. Net Asset Quality Index by Year (2017–2025)
Guangdong Lifestrong Pharmacy Co. Ltd. net asset quality index by year from 2017 to 2025. The table below presents the year-by-year Net Asset Quality Index for Guangdong Lifestrong Pharmacy Co. Ltd. from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Guangdong Lifestrong Pharmacy Co. Ltd. (301111) total market value.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 84.0% | CN¥751.22 Million | CN¥894.13 Million | CN¥142.91 Million | ▲ +1.9 pp |
| 2024 | 82.2% | CN¥766.75 Million | CN¥933.17 Million | CN¥166.42 Million | ▼ -8.8 pp |
| 2023 | 91.0% | CN¥778.21 Million | CN¥855.54 Million | CN¥77.33 Million | ▲ +2.4 pp |
| 2022 | 88.5% | CN¥758.67 Million | CN¥857.06 Million | CN¥98.39 Million | ▼ -2.4 pp |
| 2021 | 90.9% | CN¥750.85 Million | CN¥826.20 Million | CN¥75.34 Million | ▲ +6.6 pp |
| 2020 | 84.3% | CN¥323.41 Million | CN¥383.78 Million | CN¥60.37 Million | ▲ +0.7 pp |
| 2019 | 83.5% | CN¥271.68 Million | CN¥325.26 Million | CN¥53.57 Million | ▲ +6.3 pp |
| 2018 | 77.3% | CN¥229.97 Million | CN¥297.61 Million | CN¥67.64 Million | ▲ +18.0 pp |
| 2017 | 59.2% | CN¥166.37 Million | CN¥280.91 Million | CN¥114.55 Million | — |